WHITMIRE HIGH-VOLUME BUSINESS TO CHAINS, HOSPITALS AND MANAGED CARE OPERATIONS GENERATED $2.14 BIL. IN SALES IN FY 1993; KMART WAS EMERGING AS IMPORTANT
Executive Summary
Whitmire Distribution was negotiating with Kmart to act as primary supplier for the majority of the mass merchandiser's 1,650 pharmacies when Kmart divested its 572-outlet PayLess Drug Division in December, according to a disclosure by Whitmire in proxy materials on its pending merger with Cardinal Distribution.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth